Identification and Characterisation of a Novel Pathogenic Mutation in the Human Lipodystrophy Gene AGPAT2: C48R: A Novel Mutation in AGPAT2

類似資料

• Erratum to: Identification and Characterisation of a Novel Pathogenic Mutation in the Human Lipodystrophy Gene AGPAT2: C48R: A Novel Mutation in AGPAT2
  著者:: Ramanathan, N., 等
  出版事項: (2012)
• Analysis of naturally occurring mutations in the human lipodystrophy protein seipin reveals multiple potential pathogenic mechanisms
  著者:: Sim, M. F. Michelle, 等
  出版事項: (2013)
• Alterations in Lipid Signaling Underlie Lipodystrophy Secondary to AGPAT2 Mutations
  著者:: Subauste, Angela R., 等
  出版事項: (2012)
• Leptin: a novel therapeutic role in lipodystrophy
  著者:: Savage, D.B., 等
  出版事項: (2002)
• Metreleptin and Metformin Use in an Infant With Congenital Generalized Lipodystrophy Secondary to AGPAT2 Mutation
  著者:: Schweisberger, Cintya, 等
  出版事項: (2021)